ArticleBritish journal of clinical pharmacology2020
Multi-site evaluation of partnered pharmacist medication charting and in-hospital length of stay.
Article in British journal of clinical pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.
- Medication Management Strategies at Hospital Admission: A Systematic Review and Meta-Analysis.Clinical and translational science · 2026Pooled it
- A randomised trial of pharmacist-led discharge prescribing in an Australian geriatric evaluation and management service.International journal of clinical pharmacy · 2021Trial
- Patient perspectives and experiences of collaborative pharmacist prescribing in the hospital inpatient setting: a cross-sectional survey.International journal of clinical pharmacy · 2026Article
- What Deprescribing Information Should Be Communicated on Discharge and How? A Qualitative Study of Pharmacists' Perspectives on Deprescribing at Transitions of Care.Australasian journal on ageing · 2026Article
- Evaluating medication discrepancies and harm: a matched cohort study of collaborative pharmacist prescribing in a statewide healthcare system using electronic prescribing.International journal of clinical pharmacy · 2026Article
- The incidence of medication errors on discharge prescriptions following pharmacist discharge prescription planning (PDPP) in an orthopaedic surgery unit: a parallel group-controlled study.Journal of orthopaedic surgery and research · 2025Article
- A multi-site evaluation of clinical pharmacist time, motion, interventions and interruptions.International journal of clinical pharmacy · 2025Article
- Nexus of Quality Use of Medicines, Pharmacists' Activities, and the Emergency Department: A Narrative Review.Pharmacy (Basel, Switzerland) · 2024Review
- Measuring the impact of pharmaceutical care bundle delivery on patient outcomes: an observational study.International journal of clinical pharmacy · 2024Observational
- Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach.International journal of clinical pharmacy · 2024Article
- A cohort study comparing pharmacist activities during participation in general medical ward rounds: telehealth versus in-person during the COVID-19 pandemic.International journal of clinical pharmacy · 2024Article
- One Year Evaluation of Pharmacist Medication Charting Service in a Principal Referral Women and Newborn Hospital.Hospital pharmacy · 2024Article
- Partnered pharmacist medication charting and prescribing in Australian hospitals.Australian prescriber · 2024Review
- Regular Medications in the Emergency Department Short Stay Unit (ReMedIES): Can Prescribing be Improved Without Increasing Resources?Hospital pharmacy · 2024Article
- A health integrated platform for pharmacy clinical intervention data management and intelligent visual analytics and reporting.Exploratory research in clinical and social pharmacy · 2023Article
- Accuracy of antibacterial indication documentation in an electronic medicines management system.JAC-antimicrobial resistance · 2023Article
- Impact of Partnered Pharmacist Medication Charting (PPMC) on Medication Discrepancies and Errors: A Pragmatic Evaluation of an Emergency Department-Based Process Redesign.International journal of environmental research and public health · 2023Article
- The impact of partnered pharmacist medication charting in the emergency department on the use of potentially inappropriate medications in older people.Frontiers in pharmacology · 2023Article
- The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin-A Pilot Study.Pharmacy (Basel, Switzerland) · 2022Article
- Hospital pharmacists' experiences of participating in a partnered pharmacist medication charting credentialing program: a qualitative study.BMC health services research · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
aimsTo undertake a multicentre evaluation of translation of a partnered pharmacist medication charting (PPMC) model in patients admitted to general medical units in public hospitals in the state of Victoria, Australia.
methodsUnblinded, prospective cohort study comparing patients before and after the intervention. Conducted in seven public hospitals in Victoria, Australia from 20 June 2016 to 30 June 2017. Patients admitted to general medical units were included in the study. Medication charting by pharmacists using a partnered pharmacist model was compared to traditional medication charting. The primary outcome variable was the length of inpatient hospital stay. Secondary outcome measures were medication errors detected within 24 h of the patients' admission, identified by an independent pharmacist assessor.
resultsA total of 8648 patients were included in the study. Patients who had PPMC had reduced median length of inpatient hospital stay from 4.7 (interquartile range 2.8-8.2) days to 4.2 (interquartile range 2.3-7.5) days (P < 0.001). PPMC was associated with a reduction in the proportion of patients with at least 1 medication error from 66% to 3.6% with a number needed to treat to prevent 1 error of 1.6 (95% confidence interval: 1.57-1.64).
conclusionExpansion of the partnered pharmacist charting model across multiple organisations was effective and feasible and is recommended for adoption by health services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.